162 related articles for article (PubMed ID: 26171255)
1. Severe Dextran-Induced Anaphylactic Shock during Induction of Hypertension-Hypervolemia-Hemodilution Therapy following Subarachnoid Hemorrhage.
Shiratori T; Sato A; Fukuzawa M; Kondo N; Tanno S
Case Rep Crit Care; 2015; 2015():967560. PubMed ID: 26171255
[TBL] [Abstract][Full Text] [Related]
2. Effects of hypervolemia and hypertension on regional cerebral blood flow, intracranial pressure, and brain tissue oxygenation after subarachnoid hemorrhage.
Muench E; Horn P; Bauhuf C; Roth H; Philipps M; Hermann P; Quintel M; Schmiedek P; Vajkoczy P
Crit Care Med; 2007 Aug; 35(8):1844-51; quiz 1852. PubMed ID: 17581487
[TBL] [Abstract][Full Text] [Related]
3. [Severe dextran-induced anaphylactic/anaphylactoid reaction despite preventive hapten administration].
Allhoff T; Lenhart FP
Infusionsther Transfusionsmed; 1993 Dec; 20(6):301-6. PubMed ID: 7511449
[TBL] [Abstract][Full Text] [Related]
4. [Cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Therapeutic value of treatment with calcium antagonists, hypervolemic hemodilution and induced arterial hypertension].
Hansen D; Hannemann L; Specht M; Schaffartzik W
Anaesthesist; 1995 Apr; 44(4):219-29. PubMed ID: 7785750
[TBL] [Abstract][Full Text] [Related]
5. Adverse reactions to dextran in Sweden 1970-1979.
Ljungström KG; Renck H; Strandberg K; Hedin H; Richter W; Widerlöv E
Acta Chir Scand; 1983; 149(3):253-62. PubMed ID: 6193664
[TBL] [Abstract][Full Text] [Related]
6. Risk of hemorrhage from unsecured, unruptured aneurysms during and after hypertensive hypervolemic therapy.
Hoh BL; Carter BS; Ogilvy CS
Neurosurgery; 2002 Jun; 50(6):1207-11; discussion 1211-2. PubMed ID: 12015837
[TBL] [Abstract][Full Text] [Related]
7. Haemodynamic augmentation in the treatment of vasospasm in aneurysmal subarachnoid hemorrhage.
Gura M; Elmaci I; Cerci A; Sagiroglu E; Coskun KK
Turk Neurosurg; 2012; 22(4):435-40. PubMed ID: 22843460
[TBL] [Abstract][Full Text] [Related]
8. [Measurement of serum colloid oncotic pressure as a parameter of hemodilution and hemoconcentration in hypervolemic-hyperdynamic therapy for symptomatic vasospasm].
Tone O; Ito U; Tomita H; Masaoka H; Tominaga B
No Shinkei Geka; 1993 May; 21(5):437-41. PubMed ID: 8321402
[TBL] [Abstract][Full Text] [Related]
9. [Severe adverse event following iv administration of 10 ml 6% Dextran60 (0.6 g) in a healthy volunteer].
Lehmann G; Asskali F; Förster H
Anaesthesist; 2002 Oct; 51(10):820-4. PubMed ID: 12395173
[TBL] [Abstract][Full Text] [Related]
10. [Protective measures against cerebral ischemia following subarachnoid hemorrhage: Part 1].
Romero Kräuchi O; Verger Bennasar AM
Rev Esp Anestesiol Reanim; 2011 Apr; 58(4):230-5. PubMed ID: 21608279
[TBL] [Abstract][Full Text] [Related]
11. Incidence, pathomechanism and prevention of dextran-induced anaphylactoid / anaphylactic reactions in man.
Hedin H; Richter W; Messmer K; Renck H; Ljungström KG; Laubenthal H
Dev Biol Stand; 1980; 48():179-89. PubMed ID: 6168503
[TBL] [Abstract][Full Text] [Related]
12. Effects of iso- and hypervolemic hemodilution on regional cerebral blood flow and oxygen delivery for patients with vasospasm after aneurysmal subarachnoid hemorrhage.
Ekelund A; Reinstrup P; Ryding E; Andersson AM; Molund T; Kristiansson KA; Romner B; Brandt L; Säveland H
Acta Neurochir (Wien); 2002 Jul; 144(7):703-12; discussion 712-3. PubMed ID: 12181704
[TBL] [Abstract][Full Text] [Related]
13. Value of triple H therapy in a patient with an ischemic penumbra following subarachnoid hemorrhage: a case study.
Ogungbo B; Prakash S; Ushewokunze S; Etherson K; Sinar J
J Neurosci Nurs; 2005 Dec; 37(6):326-8, 333. PubMed ID: 16396086
[TBL] [Abstract][Full Text] [Related]
14. Hemorheological and hemodynamic analysis of hypervolemic hemodilution therapy for cerebral vasospasm after aneurysmal subarachnoid hemorrhage.
Mori K; Arai H; Nakajima K; Tajima A; Maeda M
Stroke; 1995 Sep; 26(9):1620-6. PubMed ID: 7660409
[TBL] [Abstract][Full Text] [Related]
15. Combined drug therapy with diltiazem, dextran, and hydrocortisone (DDH therapy) for late cerebral vasospasm after aneurysmal subarachnoid hemorrhage: assessment of efficacy and safety in an open clinical study.
Kawano T; Kazekawa K; Nakashima S; Kohno H; Tanaka N; Honma T; Kaneko Y; Satoh K
Int J Clin Pharmacol Ther; 1995 Sep; 33(9):513-7. PubMed ID: 8520810
[TBL] [Abstract][Full Text] [Related]
16. Anaphylactoid reactions to Dextran 40 and 70: reports to the United States Food and Drug Administration, 1969 to 2004.
Zinderman CE; Landow L; Wise RP
J Vasc Surg; 2006 May; 43(5):1004-9. PubMed ID: 16678697
[TBL] [Abstract][Full Text] [Related]
17. Cerebral Vasospasm Following Subarachnoid Hemorrhage.
Topcuoglu MA; Pryor JC; Ogilvy CS; Kistler JP
Curr Treat Options Cardiovasc Med; 2002 Oct; 4(5):373-384. PubMed ID: 12194810
[TBL] [Abstract][Full Text] [Related]
18. Effect of 5% albumin solution on sodium balance and blood volume after subarachnoid hemorrhage.
Mayer SA; Solomon RA; Fink ME; Lennihan L; Stern L; Beckford A; Thomas CE; Klebanoff LM
Neurosurgery; 1998 Apr; 42(4):759-67; discussion 767-8. PubMed ID: 9574640
[TBL] [Abstract][Full Text] [Related]
19. Relative importance of hypertension compared with hypervolemia for increasing cerebral oxygenation in patients with cerebral vasospasm after subarachnoid hemorrhage.
Raabe A; Beck J; Keller M; Vatter H; Zimmermann M; Seifert V
J Neurosurg; 2005 Dec; 103(6):974-81. PubMed ID: 16381183
[TBL] [Abstract][Full Text] [Related]
20. [A case of anaphylactoid shock occurring immediately after the initiation of second intravenous administration of high-dose immunoglobulin (IVIg) in a patient with Crow-Fukase syndrome].
Takahashi T; Ono S; Ogawa K; Tamura M; Mizutani T
Rinsho Shinkeigaku; 2003 Jun; 43(6):350-5. PubMed ID: 14503355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
